HuGE Literature Finder
Records
1
-
9
| Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia. Hemoglobin 2018 Mar 42 (2): 96-102. Belhaj Nefissi Rim, Doggui Radhouene, Ouali Faida, Messaoud Taieb, Gritli Nasreddi |
| Genetic polymorphisms and cerebrovascular disease in children with sickle cell anemia from Rio de Janeiro, Brazil. Arquivos de neuro-psiquiatria 2011 Jun 69 (3): 431-5. Filho Isaac Lima da Silva, Leite Ana Claudia Celestino Bezerra, Moura Patrícia Gomes, Ribeiro Georgina Severo, Cavalcante Andréa Cony, Azevedo Flávia Carolina Marques de, Andrada-Serpa Maria José |
| Hypercoagulable state and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with beta-thalassemia major in Kuwait. Acta haematologica 2010 123 (1): 37-42. Mustafa Nada Y, Marouf Rajaa, Al-Humood Salah, Al-Fadhli Suad M, Mojiminiyi Oluseg |
| The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009 Dec 20 (8): 675-8. Al-Sweedan Suleimman A, Jaradat Said, Iraqi Muna, Beshtawi Moham |
| Congenital thrombotic risk factors in beta-thalassemia. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009 Oct 15 (5): 581-4. Sipahi Tansu, Kara Aslihan, Kuybulu Ayca, Egin Yonca, Akar Nej |
| Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran. Journal of thrombosis and thrombolysis 2008 Dec 26 (3): 229-33. Rahimi Zohreh, Ghaderi Mandana, Nagel Ronald L, Muniz Adria |
| Screening for inherited thrombophilia might be warranted among Eastern Mediterranean sickle-beta-0 thalassemia patients. Journal of thrombosis and thrombolysis 2006 Oct 22 (2): 121-3. Isma'eel Hussain, Arnaout M S, Shamseddeen Wael, Mahfouz R, Zeineh N, Jradi Oussama, Taher A |
| The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease. Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 2006 Oct 39 (10): 1291-5. Moreira Neto F, Lourenço D M, Noguti M A E, Morelli V M, Gil I C P, Beltrão A C S, Figueiredo M |
| The methylene tetrahydrofolate reductase (C677T) mutation as a potential risk factor for avascular necrosis in sickle cell disease. Hemoglobin 2001 May 25 (2): 213-7. Kutlar A, Kutlar F, Turker I, Tural C |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 20, 2022
- Content source: